GWM
BNTX icon

Geneos Wealth Management’s BioNTech BNTX Stock Holding History

Geneos Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-56
Closed -$6.38K – 3083
2024
Q4 		$6.38K Buy
56
+46
+460% +$5.25K ﹤0.01% 2235
2024
Q3 		$1.19K Buy
+10
New +$919 ﹤0.01% 2414

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Geneos Wealth Management's BNTX Position: Q1 2025 in Review

Geneos Wealth Management sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 56 shares — an estimated $6.38K sold.

Geneos Wealth Management first reported a position in BNTX in Q3 2024 and held it in 2 quarters. The position peaked at $6.38K in Q4 2024. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Geneos Wealth Management reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 56 BioNTech shares in Q1 2025, an estimated $6.38K.
  • Geneos Wealth Management first reported a position in BioNTech in Q3 2024 and held it in 2 quarters.
  • Geneos Wealth Management's BioNTech position peaked at $6.38K in Q4 2024.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Geneos Wealth Management's 13F filing for Q1 2025, filed 8 May 2025.